Predilife S.A. | Small-cap | Healthcare
€3.18
-0.62%
| Predilife S.A Stock Comparison:
Predilife S.A vs bioMérieux S.APredilife S.A vs Eurofins ScientificPredilife S.A vs Eurofins Cerep SASPredilife S.A vs Klea HoldingPredilife S.A vs Lumibird S.APredilife S.A vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 2.4M
Total Liabilities 6.7M
Shareholders Equity -4.3M

Cash Flow Metrics

Revenue & Profitability Trend

Predilife S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i618.1K317.8K288.7K142.7K282.2K
Cost of Goods Sold i13.8K10.9K36.2K49.3K38.6K
Gross Profit i604.2K306.9K252.5K93.4K243.6K
Gross Margin % i97.8%96.6%87.5%65.4%86.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i---1.2M793.1K
Other Operating Expenses i2.2M2.1M1.9M1.7M284.4K
Total Operating Expenses i2.2M2.1M1.9M2.9M1.1M
Operating Income i-4.0M-3.8M-3.5M-3.5M-2.5M
Operating Margin % i-645.0%-1,208.2%-1,211.7%-2,460.5%-881.3%
Non-Operating Items
Interest Income i36.1K31068--
Interest Expense i858.4K616.9K300.7K188.8K44.0K
Other Non-Operating Income-----
Pre-tax Income i-4.8M-4.5M-3.8M-3.7M-2.5M
Income Tax i-342.4K-232.1K-256.1K-294.8K-290.3K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i198.6M-4.2M-3.6M-3.4M-2.3M
Net Margin % i32,137.4%-1,326.7%-1,262.9%-2,385.6%-797.5%
Key Metrics
EBITDA i-4.0M-3.8M-3.5M-3.5M-2.5M
EPS (Basic) i-€-1.14€-1.00€-0.93€-0.64
EPS (Diluted) i-€-1.14€-1.00€-0.93€-0.64
Basic Shares Outstanding i-3720277372027736457233516550
Diluted Shares Outstanding i-3720277372027736457233516550

Income Statement Trend

Predilife S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i1.1M2.5M3.7M2.8M3.1M
Short-term Investments i-918.2K94.4K94.9K86.3K
Accounts Receivable i430.4K176.6K134.0K107.6K31.1K
Inventory i---8.8K-
Other Current Assets--1-111
Total Current Assets i2.0M3.3M4.6M3.7M3.8M
Non-Current Assets
Property, Plant & Equipment i18.7K18.7K---
Goodwill i021.2K---
Intangible Assets i-21.2K---
Long-term Investments-----
Other Non-Current Assets-----
Total Non-Current Assets i458.1K1.1M4.6M270.7K288.4K
Total Assets i2.4M4.4M9.2M4.0M4.1M
Liabilities
Current Liabilities
Accounts Payable i420.2K336.3K249.7K179.0K208.5K
Short-term Debt i493.7K428.4K52.4K351.4K-
Current Portion of Long-term Debt-----
Other Current Liabilities-249.9K383.3K20.7K221.9K
Total Current Liabilities i1.7M710.1K1.2M400.3K637.7K
Non-Current Liabilities
Long-term Debt i4.5M7.4M7.0M5.1M2.7M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities564.3K169.8K2.0M1221.9K
Total Non-Current Liabilities i5.0M7.6M7.0M5.1M2.7M
Total Liabilities i6.7M8.3M8.2M5.5M3.4M
Equity
Common Stock i94.1K93.0K91.5K91.5K87.3K
Retained Earnings i-4.3M-4.2M-13.9M-3.4M-2.3M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i-4.3M-3.9M957.0K-1.6M721.7K
Key Metrics
Total Debt i4.9M7.9M7.1M5.5M2.7M
Working Capital i291.8K2.6M3.4M3.3M3.2M

Balance Sheet Composition

Predilife S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-4.3M-4.2M-3.7M-3.4M-2.3M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i00000
Operating Cash Flow i-4.3M-4.2M-3.7M-3.4M-2.3M
Investing Activities
Capital Expenditures i-5.4K-42.4K7.7K-3.4K-15.7K
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-706.4K-42.4K7.7K-10.6K-33.7K
Financing Activities
Share Repurchases i--12.9K-12.4K-8.6K-
Dividends Paid i-----
Debt Issuance i3.8M3.6M2.4M2.6M1.4M
Debt Repayment i-2.4M-96.7K-193.2K-157.8K-95.8K
Financing Cash Flow i2.2M3.0M4.0M3.5M5.0M
Free Cash Flow i-3.7M-4.3M-3.1M-3.8M-2.1M
Net Change in Cash i-2.7M-1.2M305.7K86.6K2.7M

Cash Flow Trend

Predilife S.A Key Financial Ratios

Valuation Ratios

Forward P/E -2.08
Price to Sales 24.88

Profitability Ratios

Profit Margin 97.76%
Operating Margin -558.18%
Return on Equity -4,653.75%
Return on Assets -73.10%

Financial Health

Current Ratio 1.38
Debt to Equity -1.16
Beta 0.38

Per Share Data

EPS (TTM) €-1.19
Book Value per Share €-3.50
Revenue per Share €0.13

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
alpre12.3M---4,653.75%97.76%-1.16
bioMérieux S.A 15.0B35.003.5710.68%10.86%11.65
Eurofins Scientific 12.2B30.013.538.68%6.05%88.06
Eurofins Cerep SAS 92.8M12.97-10.49%17.67%0.46
Klea Holding 64.5M17.872.275.35%8.14%21.13
Lumibird S.A 400.6M70.002.022.91%2.71%81.34

Financial data is updated regularly. All figures are in the company's reporting currency.